Shortening the path between the smallest and biggest companies is integral to the success of our model. Startups need insight into the most compelling applications for their technology as well as the data required to attract partnerships. Big companies crave the innovation the exciting startups in QB3@953 are developing. Through alliances that involve seminars, office hours, and “Golden Tickets”, our early stage partnerships give industry leaders awareness and access to life science’s most promising emergent technologies.

Founding Partner MBC San Francisco

Johnson & Johnson Innovation, LLC focuses on accelerating early-stage innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of innovations to solve unmet needs in patients.

Founding Partner MBC San Carlos

Founded in 1918, Nitto Denko Corporation is Japan’s leading materials manufacturer, offering over 13,500 diversified industrial products to more than 70 business fields such as electronics, automobiles, ecology, and life science. Since its initial success with transdermal drug delivery patches in the late 1970s, Nitto has been expanding its footprint in life science including siRNA-based drug discovery and biodegradable drug delivery systems (Nitto Biopharma, Inc.), GLP/GMP-grade oligo-nucleotide manufacturing (Nitto Denko Avecia Inc.), and analytical and process development services (Nitto Avecia Pharma Services Inc.). As the founding partner for the San Carlos facility, Nitto is proud to work with MBC Biolabs to support innovative startup companies sharply focusing on unmet medical needs.

Platinum Partners

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.

GSK – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. As GSK and through our heritage companies, we have a 150-year legacy of applying science to discover and develop new medicines, vaccines and consumer healthcare products that help to transform lives. Our Pharmaceuticals R&D organization is focused on research across four therapy areas – two core areas where we already have strong leadership developing new medicines: Respiratory and HIV/infectious diseases; and two potential areas where we have ongoing development programs: Oncology and immuno-inflammation. We also invest significantly in broader early discovery research, incubating areas of science outside our four core therapy areas where we think there is the potential to develop transformational medicines. This currently includes research into neuroscience and global health.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. Formore than 150 years, Pfizer has worked to make a difference for all who rely on us.
Working together for a healthier world®

Gold Partners

American Laboratory Trading (ALT) provides asset management services and high-quality refurbished laboratory equipment to thousands of clients in the life sciences, from academia to industry. As the largest supplier of premium used lab equipment in North America, ALT stocks more than 12,000 instruments, ranging from benchtop accessories to robust triple quad mass spectrometers.
ALT is also a trusted provider of laboratory asset management services, helping companies and research institutions to safely dispose of and recycle their surplus laboratory equipment while maximizing their return on investment.
With sales, service, and warehouse facilities in Connecticut and Southern California, American Laboratory Trading offers equipment and services from coast to coast and around the world, serving customers in more than 60 countries.

In the original association with GE Healthcare, UCSF physicians and GE researchers evaluated how best to apply magnetic resonance imaging technology to patient care at the UCSF Department of Radiology. The relationship has since expanded and resulted in the formation of the Surbeck Laboratory for Advanced Imaging at Byers Hall. The goals of this laboratory are to increase the sensitivity and specificity of in vivo MR and to develop anatomic, functional, and metabolic imaging techniques for applications in biology and medicine. The Surbeck Laboratory links imaging specialists, bioengineers, and clinicians from academia with collaborators from GE Healthcare. Additionally, it gives students from UCSF and UC Berkeley the oppor­tunity to obtain hands-on experience in obtaining and analyzing high-field MR imaging and spectroscopic data.

The global leader in beauty with a portfolio of over 30 brands, and with a Research & Innovation workforce of nearly 4,000 people, L’Oréal continues to innovate by bringing breakthrough products and technologies to consumers around the world. In 2012, the company opened its U.S. based Technology Incubator, a division within L’Oréal’s Research & Innovation arm dedicated to meeting the needs of consumers through disruptive tech innovations. Designed as a startup, the incubator partners with experts across disciplines, to develop research and first-to-market technologies.

Miltenyi Biotec’s mission is to improve scientific understanding and medical progress. We innovate products that address sample preparation, separation of cells and their analysis, and that advance the concept of cellular therapy. We provide products and services that advance biomedical research and cellular therapy. Honoring this mission drives our commitment to support the translation of basic research into therapy in the areas of immunology, cancer, neuroscience and stem cell biology. “Researchers working for researchers” is our promise to provide pioneering products to our customers.

Servier is the second largest French pharmaceutical company. They specialize in therapeutics for cardiology, oncology, rheumatological conditions, diabetes and CNS diseases. Looking for innovative new approaches and products, Servier has partnered with QB3@953 to find and cultivate innovative startups.

Toray Group combines nanotechnology with its core technologies of organic synthetic chemistry, polymer chemistry and biotechnology, based on which it globally develops the Foundation Businesses of fibers & textiles and plastics & chemicals as well as businesses such as IT-related products, carbon fiber composite materials, pharmaceuticals & medical products, environment & engineering including water treatment.

VWR International, LLC, headquartered in Radnor, Pennsylvania, is a global provider of laboratory supplies, equipment and services with worldwide sales in excess of $4.1 billion in 2012. VWR enables the advancement of the world’s most critical research by providing product and service solutions to laboratories and production facilities in the pharmaceutical, biotech, industrial, educational, governmental and healthcare industries. With over 160 years of industry experience, VWR offers a well-established network that reaches thousands of specialized labs and facilities spanning the globe. VWR has over 8,000 associates around the world working to streamline the way scientists, researchers, medical professionals and engineers across the Americas, Europe and Asia Pacific stock and maintain their facilities. In addition, VWR further supports its customers by providing onsite services, storeroom management, product procurement, supply chain systems integration and technical services.

Silver Partners

ACEA Biosciences is pioneering the development and commercialization of high performance, cutting edge cell analysis instruments for life science research and clinical diagnostics.

xCELLigence® Real-Time Cell Analysis (RTCA) instruments enable label-free, real-time monitoring of cell proliferation, cytotoxicity, cell size/morphology, cell-substrate attachment quality, and cell invasion/migration. The flexibility, sensitivity, and reproducibility of RTCA make it a standout amongst cell-based assay platforms.

ACEA’s line of NovoCyte® Flow Cytometers is raising the bar for what is expected of benchtop machines by designing and producing high performance, customizable benchtop cytometers at accessible price points. By including features such as 15 fluorescence detection channels with 3 lasers, direct volumetric based cell counting, and a versatile high throughput walkaway autosampler,

xCELLigence and NovoCyte instruments are currently being used worldwide in academic, industrial, and hospital labs for preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, clinical diagnostics, and basic research.

Mission Bay Capital is an early-stage life-science venture fund dedicated to helping entrepreneurial scientist create successful companies. We do this because we believe that startups are the most efficient engine for positive change. The passion and purpose that entrepreneurs bring turn ideas into solutions. These small companies take-on oversized problems like chronic diseases and global environmental challenges, and with seemingly inadequate resources they succeed. We want to help.

TetraScience enables laboratories, like our own, to connect existing instruments to a single online dashboard where we can manage experiments and access data. TetraScience and QB3 are looking forward to building upon our existing relationship and getting member companies involved.

TriNet provides small and midsize businesses with a Full-Service HR solution so they can free themselves from the complexities of HR and focus on their goals. As their trusted HR business partner, TriNet assumes many of the responsibilities of being an employer and helps these companies contain HR costs, minimize employer-related risks and relieve the administrative burden of HR. TriNet offers bundled HR products tailored by industry and strategic HR services, resulting in a comprehensive and empowering solution.

Wilson Sonsini Goodrich & Rosati is the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, as well as the public and private capital markets that finance them. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations. Since the firm’s inception in the early days of Silicon Valley, we have been privileged to help lay the groundwork for some of the world’s most innovative companies. In fact, as the nation’s leading law firm representing venture-backed companies, we have counseled thousands of entrepreneurs starting new businesses, advising on company formation, equity structures, negotiations with investors, intellectual property rights, and other issues vital to their success. Our clients span a wide variety of industries, including information technology, life sciences, energy and clean technology, media and entertainment, communications, retail, and financial services.

Upcoming Event

  • San Carlos Open House

    Come to meet MBC BioLabs residents, tour our new space in San Carlos, and hear about our exciting plans for the future. There will be posters from our companies, a live band, and an opportunity to chat with our partners and staff. RSVP In just 4 years, we have helped 116 entrepreneurial teams create fast, focused and frugal biotech companies that have gone on to raise $2.4 billion and counting. With this new facility, we can empower more entrepreneurs with the space and resources they need to tackle world changing science. Come join us in celebrating our newest MBC Biolabs campus and welcome our residents and partners!


953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter